RNS Number : 2538X Renalytix PLC 04 January 2022 Renalytix plc ("Renalytix" or the "Company") American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population National program establishes early care management, technology innovation and large
RNS Number : 0925W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Result of AGM LONDON and SALT LAKE , 17 December 2021 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were
RNS Number : 0593W Renalytix PLC 17 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000
RNS Number : 3617V Renalytix PLC 13 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of
RNS Number : 1070V Renalytix PLC 09 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of
RNS Number : 9024U Renalytix PLC 08 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
RNS Number : 7546U Renalytix PLC 07 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , December 7, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial
RNS Number : 2978U Renalytix PLC 02 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 LONDON and SALT LAKE CITY , December 2, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the
RNS Number : 0262T Renalytix PLC 19 November 2021 Renalytix plc ("Renalytix" or the "Company") Publication of Annual Report 2021 and Notice of 2021 Annual General Meeting LONDON and SALT LAKE CITY , November 19, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual
RNS Number : 8663R Renalytix PLC 10 November 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Convenes Expert Panel at VA Healthcare Summit Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease NEW
